Importancia de la codificació n tras el diagnó stico de enfermedad renal cró nica: del có digo N18.9 (CIE/ICD-10) al papel de los laboratorios clínicos.

Saved in:

Bibliographic Details
Title:	Importancia de la codificació n tras el diagnó stico de enfermedad renal cró nica: del có digo N18.9 (CIE/ICD-10) al papel de los laboratorios clínicos.
Alternate Title:	The importance of disease coding following the diagnosis of chronic kidney disease: from ICD-10 code N18.9 to the role of clinical laboratories.
Authors:	Troya, María Isabel¹, Bover, Jordi¹ jbover.ics@gencat.cat, Cia Hidalgo, Anna², Malumbres, Susana³, Sánchez-Bayá, Maya¹, Massó, Elisabet¹, Coll-Brito, Verónica¹, Anton-Pampols, Paula¹, da Silva, Iara¹, Soler-Majorala, Jordi¹, Marcos, Elisabeth¹, Moreiras Abril, Beatriz⁴, Pérez-León, Noemí⁵, Morera García, Marta⁶, Golf Zaragoza, Joan Pau⁶, Jusmet Miguel, Xavier⁶, Lejardi Estevez, Yolanda⁶, López-Alarcón, Rosa², Blanco, Ignacio³, Morales Indiano, Cristian⁷
Source:	Nefrologia. Nov2025, Vol. 45 Issue 9, p1-3. 3p.
Subjects:	CHRONIC kidney failure, MEDICAL coding, PATIENT monitoring, PATHOLOGICAL laboratories, INTERNATIONAL Statistical Classification of Diseases & Related Health Problems, MEDICAL cooperation, DISEASE management
Abstract (English):	The article addresses the importance of coding following the diagnosis of chronic kidney disease (CKD), specifically the code N18.9 from the ICD-10, and the role of clinical laboratories in this process. It emphasizes that proper coding of CKD is crucial for improving its detection and management, as it is associated with slower disease progression and greater use of nephroprotective therapies. Despite advancements in the identification and coding of CKD, it is noted that many diagnosed patients do not have appropriate coding, which limits effective monitoring and treatment. The article suggests that collaboration among all stakeholders in the healthcare system, including clinical laboratories, is essential to optimize the care and treatment of CKD. [Extracted from the article]
Abstract (Spanish):	El artículo aborda la importancia de la codificación tras el diagnóstico de la enfermedad renal crónica (ERC), específicamente el código N18.9 del CIE/ICD-10, y el papel de los laboratorios clínicos en este proceso. Se destaca que la adecuada codificación de la ERC es crucial para mejorar su detección y manejo, ya que está asociada a una menor progresión de la enfermedad y un mayor uso de terapias nefroprotectoras. A pesar de los avances en la identificación y codificación de la ERC, se señala que muchos pacientes diagnosticados no tienen una codificación adecuada, lo que limita el seguimiento y tratamiento efectivo. El artículo sugiere que la colaboración de todos los actores del sistema sanitario, incluidos los laboratorios clínicos, es esencial para optimizar la atención y el tratamiento de la ERC. [Extracted from the article]
	Copyright of Nefrologia is the property of Revista Nefrologia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	MedicLatina

Description
Abstract:	The article addresses the importance of coding following the diagnosis of chronic kidney disease (CKD), specifically the code N18.9 from the ICD-10, and the role of clinical laboratories in this process. It emphasizes that proper coding of CKD is crucial for improving its detection and management, as it is associated with slower disease progression and greater use of nephroprotective therapies. Despite advancements in the identification and coding of CKD, it is noted that many diagnosed patients do not have appropriate coding, which limits effective monitoring and treatment. The article suggests that collaboration among all stakeholders in the healthcare system, including clinical laboratories, is essential to optimize the care and treatment of CKD. [Extracted from the article]
ISSN:	02116995
DOI:	10.1016/j.nefro.2025.501410